Workflow
股份回购注销
icon
Search documents
新智认知数字科技股份有限公司关于部分回购股份注销实施暨股份变动的公告
Core Viewpoint - The company, New Intelligence Digital Technology Co., Ltd., has announced the cancellation of 10,383,920 repurchased shares, which will reduce its total share capital and registered capital accordingly [1][3][6]. Summary by Sections Share Repurchase and Cancellation - The company held meetings on April 27, 2025, and May 29, 2025, to approve the cancellation of shares repurchased between August 20, 2024, and November 16, 2024 [1][3]. - The total number of shares to be canceled is 10,383,920, which represents 2.06% of the company's total share capital [3]. Financial Details - The repurchase was conducted at an average price of 5.84 RMB per share, with a total expenditure of 60.634 million RMB [3]. - The repurchase plan had a budget between 60 million RMB and 120 million RMB, with a maximum price of 6.75 RMB per share [2]. Changes in Share Capital - Following the cancellation, the total share capital will decrease from 504,500,508 shares to 494,116,588 shares, and the registered capital will similarly decrease from 504,500,508 RMB to 494,116,588 RMB [1][6]. - The controlling shareholder's ownership percentage will increase from 62.25% to 63.56% after the cancellation [6]. Impact on Company - The cancellation of shares and reduction of registered capital is not expected to have a significant impact on the company's financial status, operational results, or debt repayment ability [6].
罕见!上市公司回购注销太猛,股本低于4亿股,面临退市风险?
梧桐树下V· 2025-08-02 06:37
Core Viewpoint - The company, Mousse Co., Ltd. (001323), has completed a share buyback and cancellation process, reducing its total share capital and preparing for a capital reserve increase plan to meet listing requirements [2][3][7]. Summary by Sections Share Buyback and Cancellation - Mousse Co., Ltd. has repurchased a total of 4,265,977 shares, accounting for 1.07% of the company's total share capital, and completed the cancellation of these shares on July 25, 2025 [2][3]. - Following the cancellation, the total share capital decreased from 400,010,000 shares to 395,744,023 shares, with the public shareholding ratio dropping to 19.11%, which does not meet the listing requirements [3][7]. Capital Reserve Increase Plan - The company plans to propose a capital reserve increase of 1 share for every 10 shares held, which will result in an increase of 39,336,741 shares, raising the total share capital to 435,080,764 shares [6][8]. - This proposal will be submitted for approval at the upcoming extraordinary general meeting scheduled for August 13, 2025 [7]. Financial Performance - For the fiscal year 2024, Mousse Co., Ltd. reported a net profit attributable to shareholders of 767,327,852.54 yuan, a decrease of 4.36% compared to the previous year [6][8]. - The company's total revenue for 2024 was 5,602,743,692.82 yuan, reflecting a slight increase of 0.43% year-on-year [8]. - The net cash flow from operating activities significantly decreased by 43.63% to 1,090,516,939.78 yuan [8]. Company Overview - Mousse Co., Ltd. specializes in high-end health sleep products, with mattresses being its core product. The company integrates research, design, production, sales, and service [7].
远大控股: 关于回购股份注销完成暨股份变动的公告
Zheng Quan Zhi Xing· 2025-08-01 16:36
Core Viewpoint - The company has completed the cancellation of repurchased shares, reducing its registered capital and total share count, which will not materially affect its financial status or operational results [2][4][5]. Summary by Sections 1. Repurchase of Shares - The company approved a share repurchase plan in 2022, intending to buy back shares for employee stock ownership plans or equity incentives, with a total budget between RMB 30 million and RMB 60 million [2][3]. - The actual repurchase occurred from May 5, 2022, to September 2022, totaling 2,313,600 shares, which is 0.45% of the total share capital, with a total expenditure of RMB 30,000,778 [3]. 2. Cancellation of Repurchased Shares - The company decided to cancel the repurchased shares due to the absence of any current employee stock incentive plans and the nearing expiration of the three-year holding period for the repurchased shares [3][4]. - The cancellation was approved in meetings held on June 9, 2025, and June 30, 2025, leading to a reduction in total share capital from 508,940,464 shares to 506,626,864 shares [2][4]. 3. Impact on Share Structure - Post-cancellation, the share structure will show a slight increase in the proportion of restricted shares, while the overall share capital remains compliant with listing requirements [4]. - The breakdown of share types before and after the cancellation indicates that restricted shares remain at 2,910,343 shares (0.5745%), while unrestricted shares decrease to 503,716,521 shares (99.4255%) [4]. 4. Future Arrangements - Following the cancellation, the company will proceed with necessary legal and regulatory changes, including updating its registered capital and amending its articles of association [5].
德展大健康股份有限公司关于回购股份注销完成暨股份变动公告
Core Viewpoint - The company has completed the cancellation of repurchased shares, which amounts to 67,850,450 shares, representing 3.13% of the total share capital before cancellation [2][5]. Group 1: Share Repurchase Implementation - The company approved a share repurchase plan at the 2024 first extraordinary general meeting, allowing for the repurchase of shares using between RMB 200 million and RMB 300 million within 12 months [3]. - The repurchase price was set at a maximum of RMB 3.59 per share, with the funds sourced from the company's own funds and loans from financial institutions [3]. - The actual repurchase period was from September 3, 2024, to July 15, 2025, with a total of 67,850,450 shares repurchased at an average price of RMB 2.96 per share, totaling RMB 200,884,766.50 [4]. Group 2: Share Cancellation Details - The cancellation of the repurchased shares was confirmed by the China Securities Depository and Clearing Corporation on July 30, 2025, with the total share capital reduced from 2,164,955,990 shares to 2,097,105,540 shares [2][5]. - The shares were canceled from both self-funded and loan accounts, with 28,567,500 shares from self-funding and 39,282,950 shares from loans [2][5]. Group 3: Impact on Shareholder Equity - The cancellation of shares is expected to enhance earnings per share and improve shareholder returns without adversely affecting the company's financial, operational, or debt obligations [6]. - The cancellation will not change the company's control or affect its listing status [6]. Group 4: Future Arrangements - The company will amend relevant provisions in its articles of association and complete necessary business registration and filing procedures as per legal requirements [6].
三星医疗: 三星医疗关于回购股份注销实施暨股份变动公告
Zheng Quan Zhi Xing· 2025-07-30 16:25
证券代码:601567 证券简称:三星医疗 公告编号:临 2025-060 宁波三星医疗电气股份有限公司 关于回购股份注销实施暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司于2023年12月7日召开第六届董事会第六次会议,并于2023年12月25日 召开2023年第四次临时股东大会,审议通过了《关于回购公司股份方案的议案》。 同意公司使用自有资金以集中竞价的方式回购公司股份,回购资金总额不低于人 民币1.5亿元(含),不超过人民币3亿元(含),回购价格不超过人民币21.00 元/股。具体内容详见公司分别于2023年12月8日、2023年12月26日披露于上海证 券交易所网站的公告《三星医疗关于回购公司股份预案的公告》(公告编号:临 (公告编号:临2023-103)。 (二)回购股份实施情况 关于以集中竞价交易方式首次回购公司股份的公告》(公告编号:临2023-105)。 为19.30元/股,已支付的资金总额为人民币279,083,618.90元(不含印花税及交易 佣金等费用)。回购方案实际 ...
慕思股份: 关于回购股份注销完成暨股份变动的公告
Zheng Quan Zhi Xing· 2025-07-28 16:50
Core Viewpoint - The company has approved a share buyback plan to reduce registered capital by repurchasing shares using its own funds, with a total buyback amount ranging from RMB 120 million to RMB 240 million [2][3]. Buyback Plan Details - The buyback will be conducted through the Shenzhen Stock Exchange, targeting A-shares, with a maximum repurchase price set at RMB 39 per share initially, later adjusted to RMB 38.26 and then to RMB 37.28 [2][3][4]. - The estimated number of shares to be repurchased ranges from approximately 3,076,923 shares (0.77% of total shares) to 643,780 shares (1.61% of total shares) based on the maximum buyback amount [2][3]. Implementation Status - As of July 18, 2025, the company has repurchased a total of 4,265,977 shares, representing 1.07% of the total share capital, with a total transaction amount of approximately RMB 121.89 million [3][4]. - The highest transaction price during the buyback was RMB 30.07 per share, and the lowest was RMB 27.72 per share, with an average price of RMB 28.57 per share [3]. Share Cancellation - The company completed the cancellation of the repurchased shares on July 25, 2025, reducing the total share capital from 400,010,000 shares to 395,744,023 shares [3][4]. - The cancellation of shares will not significantly impact the company's operations, finances, or future development [4]. Share Structure Changes - Following the cancellation, the proportion of restricted shares increased from 78.49% to 79.34%, while the proportion of unrestricted shares decreased from 21.51% to 20.66% [4].
昊海生科: 上海昊海生物科技股份有限公司关于注销已回购H股股份的公告
Zheng Quan Zhi Xing· 2025-07-28 16:27
Group 1 - The company has completed the repurchase and cancellation of H shares, resulting in a reduction of total share capital from 233,193,695 shares to 232,581,095 shares [1][2] - The repurchase was authorized during the 2023 annual general meeting and subsequent shareholder meetings, allowing the board to proceed with the cancellation of H shares [1] - Following the cancellation, the structure of the share capital has changed, with A shares increasing from 83.2149% to 83.4341% of total shares, while H shares decreased from 16.7851% to 16.5659% [2]
华联控股股份有限公司 关于回购股份注销完成暨股份变动的公告
Core Viewpoint - The company has completed the cancellation of repurchased shares, which will positively impact its capital structure and shareholder returns [2][7][8]. Group 1: Share Repurchase and Cancellation Details - The company repurchased a total of 97,215,300 shares in 2024, with 80,115,300 shares being canceled, representing 82.41% of the repurchased shares and 5.4% of the total shares before cancellation [2][7]. - The total amount for the canceled shares was RMB 246,695,724.11, and after the cancellation, the total share capital decreased from 1,483,934,025 shares to 1,403,818,725 shares [2][7][8]. - The repurchase was approved by the board on January 10, 2024, and the total funds allocated for the repurchase were increased from RMB 5 million to a range of RMB 15 million to RMB 30 million [2][3]. Group 2: Impact on Shareholder Structure - Following the cancellation, the controlling shareholder, Hualian Group, saw its ownership percentage increase from 28.21% to 29.82% without changing the number of shares held [7][8]. - This change in ownership percentage does not trigger a mandatory tender offer and does not affect the company's governance structure or ongoing operations [8]. Group 3: Financial Implications - The cancellation of shares is treated as a cash dividend, with the amount equivalent to the repurchase value of RMB 246,695,724.11, enhancing earnings per share and net asset value [8][9]. - The company asserts that this action will not significantly impact its financial condition, debt repayment ability, or shareholder equity [8].
岩山科技: 关于回购股份注销完成暨股份变动的公告
Zheng Quan Zhi Xing· 2025-07-23 09:18
证券代码:002195 证券简称:岩山科技 公告编号:2025-042 上海岩山科技股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏。 特别提示: (以下简称"公司")总股本的 0.19%。本次注销完成后,公司总股本由 5,681,544,596 股 变 更 为 5,670,554,696 股 , 公 司 注 册 资 本 由 人 民 币 5,681,544,596 元 变 更 为 事宜已于 2025 年 7 月 22 日办理完成。 公司因实施注销回购专用证券账户股份导致公司总股本、无限售条件流通股数量发生 变化,根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号— —回购股份》等相关规定,现就回购股份注销完成暨股份变动情况公告如下: 一、本次回购股份的批准和实施情况 公司已于 2025 年 7 月 22 日在中国证券登记结算有限责任公司深圳分公司办理完毕 上述 10,989,900 股回购股份的注销事宜。本次回购股份的数量、完成日期、注销期限符 合回购股份注销相关法律法规的要求,与回购方案不存在差异。 三、本次回购股份注销后 ...
鸿泉物联: 鸿泉物联:关于变更回购股份用途并注销暨减少注册资本的公告
Zheng Quan Zhi Xing· 2025-07-21 16:26
Core Viewpoint - The company intends to change the purpose of its repurchased shares from employee stock ownership plans and maintaining shareholder value to cancellation of shares to reduce registered capital [1][7]. Group 1: Share Repurchase Details - The company plans to change the use of 1,230,216 repurchased shares, which represents 1.2175% of the current total share capital [1][7]. - The total share capital will decrease from 101,043,920 shares to 99,813,704 shares after the cancellation [6][7]. - The repurchased shares were initially intended for employee stock ownership plans and maintaining shareholder value, with a maximum repurchase price of RMB 28.00 per share and a total repurchase fund between RMB 20 million and RMB 40 million [2][3]. Group 2: Rationale and Impact - The decision to change the purpose of the repurchased shares is aimed at enhancing investor returns and confidence, thereby increasing the company's long-term investment value [3][7]. - The cancellation of shares is expected to increase earnings per share and improve shareholder returns without adversely affecting the company's financial condition or debt servicing ability [7][8]. - The company asserts that this change complies with relevant regulations and will not harm the interests of shareholders, particularly minority shareholders [7][8]. Group 3: Decision-Making Process - The board of directors approved the proposal during the meetings held on July 21, 2025, and it will be submitted for shareholder approval [8].